Mark Blaskovich
Mark Blaskovich
Group Leader, Institute for Molecular Bioscience, The University of Queensland
Verified email at - Homepage
Cited by
Cited by
Antibiotics in the clinical pipeline in 2013
MS Butler, MA Blaskovich, MA Cooper
The Journal of antibiotics 66 (10), 571-591, 2013
Antibiotics in the clinical pipeline at the end of 2015
MS Butler, MAT Blaskovich, MA Cooper
The Journal of antibiotics 70 (1), 3-24, 2017
Unusual amino acids in medicinal chemistry
MAT Blaskovich
Journal of medicinal chemistry 59 (24), 10807-10836, 2016
Glycopeptide antibiotics: back to the future
MS Butler, KA Hansford, MAT Blaskovich, R Halai, MA Cooper
The Journal of Antibiotics 67 (9), 631-644, 2014
Synthesis of a chiral serine aldehyde equivalent and its conversion to chiral. alpha.-amino acid derivatives
MA Blaskovich, GA Lajoie
Journal of the American Chemical Society 115 (12), 5021-5030, 1993
Drug discovery and protein tyrosine phosphatases
MAT Blaskovich
Current medicinal chemistry 16 (17), 2095-2176, 2009
Contribution of amphipathicity and hydrophobicity to the antimicrobial activity and cytotoxicity of β-hairpin peptides
IA Edwards, AG Elliott, AM Kavanagh, J Zuegg, MAT Blaskovich, ...
ACS infectious diseases 2 (6), 442-450, 2016
Helping chemists discover new antibiotics
MAT Blaskovich, J Zuegg, AG Elliott, MA Cooper
ACS infectious diseases 1 (7), 285-287, 2015
Stereoselective synthesis of threo and erythro β-hydroxy and β-disubstituted-β-hydroxy α-amino acids
MA Blaskovich, G Evindar, NGW Rose, S Wilkinson, Y Luo, GA Lajoie
The Journal of Organic Chemistry 63 (11), 3631-3646, 1998
Antimicrobial silver in medicinal and consumer applications: a patent review of the past decade (2007–2017)
W Sim, RT Barnard, MAT Blaskovich, ZM Ziora
Antibiotics 7 (4), 93, 2018
Quinolone antibiotics
TDM Pham, ZM Ziora, MAT Blaskovich
Medchemcomm 10 (10), 1719-1739, 2019
Activity and predicted nephrotoxicity of synthetic antibiotics based on polymyxin B
A Gallardo-Godoy, C Muldoon, B Becker, AG Elliott, LH Lash, JX Huang, ...
Journal of medicinal chemistry 59 (3), 1068-1077, 2016
Recent discovery and development of protein tyrosine phosphatase inhibitors
HO Kim, MA Blaskovich
Expert Opinion on Therapeutic Patents 12 (6), 871-905, 2002
Developments in glycopeptide antibiotics
MAT Blaskovich, KA Hansford, MS Butler, ZG Jia, AE Mark, MA Cooper
ACS infectious diseases 4 (5), 715-735, 2018
Clostridium difficile Drug Pipeline: Challenges in Discovery and Development of New Agents
AM Jarrad, T Karoli, MAT Blaskovich, D Lyras, MA Cooper
Journal of medicinal chemistry 58 (13), 5164-5185, 2015
Highly efficient and versatile synthesis of libraries of constrained β-strand mimetics
CO Ogbu, MN Qabar, PD Boatman, J Urban, JP Meara, MD Ferguson, ...
Bioorganic & medicinal chemistry letters 8 (17), 2321-2326, 1998
Nitroimidazoles: molecular fireworks that combat a broad spectrum of infectious diseases
CW Ang, AM Jarrad, MA Cooper, MAT Blaskovich
Journal of medicinal chemistry 60 (18), 7636-7657, 2017
Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis
AM Jarrad, A Debnath, Y Miyamoto, KA Hansford, R Pelingon, MS Butler, ...
European journal of medicinal chemistry 120, 353-362, 2016
Evaluation of biomarkers for in vitro prediction of drug‐induced nephrotoxicity: comparison of HK‐2, immortalized human proximal tubule epithelial, and primary cultures of …
JX Huang, G Kaeslin, MV Ranall, MA Blaskovich, B Becker, MS Butler, ...
Pharmacology research & perspectives 3 (3), e00148, 2015
Mucin binding reduces colistin antimicrobial activity
JX Huang, MAT Blaskovich, R Pelingon, S Ramu, A Kavanagh, AG Elliott, ...
Antimicrobial agents and chemotherapy 59 (10), 5925-5931, 2015
The system can't perform the operation now. Try again later.
Articles 1–20